Page last updated: 2024-09-02

caffeic acid phenethyl ester and silybin

caffeic acid phenethyl ester has been researched along with silybin in 2 studies

Compound Research Comparison

Studies
(caffeic acid phenethyl ester)
Trials
(caffeic acid phenethyl ester)
Recent Studies (post-2010)
(caffeic acid phenethyl ester)
Studies
(silybin)
Trials
(silybin)
Recent Studies (post-2010) (silybin)
840146949025

Protein Interaction Comparison

ProteinTaxonomycaffeic acid phenethyl ester (IC50)silybin (IC50)
Polyphenol oxidase 2Agaricus bisporus1.7
Trypsin-1Homo sapiens (human)3.7
Trypsin-2Homo sapiens (human)3.7
Trypsin-3Homo sapiens (human)3.7
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.2658
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)6.1659

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuda, H; Morikawa, T; Ninomiya, K; Yamaguchi, I; Yasuda, D; Yoshikawa, M1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

2 other study(ies) available for caffeic acid phenethyl ester and silybin

ArticleYear
Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides.
    Bioorganic & medicinal chemistry, 2009, Oct-15, Volume: 17, Issue:20

    Topics: Amides; Animals; Cells, Cultured; Lipopolysaccharides; Liver; Magnetic Resonance Spectroscopy; Male; Mice; Models, Molecular; Molecular Structure; Piper

2009
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012